Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• MultiMetaVerse Holdings Limited MMV gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.
• Yunji Inc. YJ gained 83.8% to $0.39 after reporting first-quarter financial results.
• U Power Limited UCAR shares climbed 65.4% to $12.55. U Power shares jumped 144% on Thursday after the company announced it entered into a framework strategic cooperation agreement with Quantum Solutions Co in Japan.
• Minerva Surgical, Inc. UTRS gained 60% to $0.32.
• Kaixin Auto Holdings KXIN climbed 33.3% to $0.40.
• Samsara Inc. IOT gained 30.3% to $24.77 after the company reported better-than-expected first-quarter results and raised its FY24 outlook.
• MongoDB, Inc. MDB shares rose 29.8% to $381.69 after the company reported upbeat results for its first quarter and issued strong projections.
• CNS Pharmaceuticals, Inc. CNSP jumped 25.2% to $2.28.
• Universal Security Instruments, Inc. UUU gained 24.6% to $3.0534.
• The Chemours Company CC jumped 24.5% to $33.76 after the company announced it agreed to sell its Glycolic Acid business to PureTech Scientific for $137 million.
• eHealth, Inc. EHTH rose 22.5% to $8.42.
• Digital Ally, Inc. DGLY shares gained 21.2% to $4.81 after the company announced its subsidiary, Kustom Entertainment, entered into a business combination agreement with Clover Leaf Capital Corp.
• Pioneer Power Solutions, Inc. PPSI rose 20.3% to $6.75 after the company announced that a major global automaker has transacted for multiple e-Boost units to support the initial rollout of autonomous EVs in several cities.
• CBAK Energy Technology, Inc. CBAT gained 19.6% to $1.2086.
• Quanex Building Products Corporation NX jumped 19.4% to $25.17 following upbeat quarterly earnings.
• LAVA Therapeutics N.V. LVTX shares gained 18.3% to $2.25. LAVA Therapeutics reported selection by Janssen of lead Gamma-Delta T-Cell engager bispecific antibody to move toward clinical development.
• TransCode Therapeutics, Inc. RNAZ climbed 17.7% to $4.64.
• Connect Biopharma Holdings Limited CNTB gained 17.5% to $1.29 as the company disclosed long-term data from the maintenance period through week 48 of CN002 Phase 2 icanbelimod trial in patients with moderate-to-severe ulcerative colitis.
• DISH Network Corporation DISH gained 17.3% to $7.36 following a Bloomberg report suggesting Amazon is in talks with Verizon, Dish and T-Mobile to offer a free or low-cost mobile service to U.S. Prime members.
• Digital Media Solutions, Inc. DMS rose 17.2% to $0.4101.
• Rain Oncology Inc. RAIN shares gained 16.7% to $1.2950. Rain Oncology recently issued update and outlined strategic priorities of milademetan clinical programs.
• Diversified Healthcare Trust DHC rose 14.6% to $1.6733. Diversified Healthcare Trust Director Adam D Portnoy acquired a total 3,154,641 shares an average price of $1.38.
• PacWest Bancorp PACW jumped 13.5% to $7.63.
• 3D Systems Corporation DDD gained 12.7% to $9.40. 3D Systems confirmed its submission of a proposal to combine with Stratasys.
• Kintara Therapeutics, Inc. KTRA surged 12.3% to $3.4687.
• Lululemon Athletica Inc. LULU rose 12% to $367.76 as the company reported better-than-expected earnings and sales results for its first quarter. For the full fiscal year, Lululemon sees revenue coming in a range of $9.44 billion to $9.51 billion, which would be up 17% year-over-year at the mid-point. Full-year earnings per share are expected to be in a range of $11.74 to $11.94.
• Stratasys Ltd. SSYS rose 10.2% to $16.05 after the company received an unsolicited non-binding indicative proposal from 3D Systems Corporation.
• Chico's FAS, Inc. CHS gained 9.4% to $4.9350.
• Macy's, Inc. M climbed 8.1% to $14.87. Macy's reported a first-quarter FY23 sales decline of 7% year-on-year to $4.98 billion.
• Dell Technologies Inc. DELL shares gained 5% to $47.76 following results for the first quarter.

Losers

Get Started

Start Futures Trading Fast — with a $200 Bonus

Join Plus500 today and get up to $200 to start trading real futures. Practice with free paper trading, then jump into live markets with lightning-fast execution, low commissions, and full regulatory protection.

Get Started

• Kiora Pharmaceuticals, Inc. KPRX shares dropped 50.1% to $0.8227 after dropping over 20% on Thursday.
• Oncorus, Inc. ONCR shares dropped 38.2% to $0.1121. Oncorus announced workforce reduction plan of 55 employees.
• SentinelOne, Inc. S shares dipped 36.5% to $13.16 after the company reported worse-than-expected first-quarter sales and issued weak second-quarter guidance.
• SunCar Technology Group Inc. SDA fell 24% to $32.92.
• PagerDuty, Inc. PD fell 18% to $22.75 after the company issued weak revenue guidance.
• SciSparc Ltd. SPRC declined 14.5% to $0.71. SciSparc announced successful final Phase IIa results, meeting end points of its Phase IIa Alzheimer disease patients with agitation trial.
• ROC Energy Acquisition Corp. ROC dropped 14.4% to $6.96.
• TRxADE HEALTH, Inc. MEDS fell 13.2% to $0.3380 after surging 39% on Thursday. TRXADE HEALTH recently reported worse-than-expected first-quarter sales results.
• Nexalin Technology, Inc. NXL fell 13.2% to $0.8010.
• Guidewire Software, Inc. GWRE dipped 13.1% to $72.00 after the company reported mixed third-quarter financial results and issued FY23 revenue guidance below the consensus estimate.
• Tilly's, Inc. TLYS fell 11.6% to $6.52 after the company reported worse-than-expected first-quarter financial results and issued second-quarter guidance below estimates.
• Kymera Therapeutics, Inc. KYMR dropped 10.3% to $26.35.
• BiomX Inc. PHGE declined 9.4% to $0.3797.
• IonQ, Inc. IONQ fell 9.1% to $9.74.
• T-Mobile US, Inc. TMUS dropped 8.8% to $126.74.
• Sight Sciences, Inc. SGHT declined 8.3% to $8.77.
• ChargePoint Holdings, Inc. CHPT shares dropped 3% to $9.47 after the company reported first-quarter results and issued weak sales guidance for the current quarter.

Now Read This: Bitcoin, Ethereum Gain Following Jobs Data; Injective Emerges As Top Gainer